Clinical Trial Update: Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating TAF in patients with suboptimal response to other nucleos(t)ides for chronic hepatitis B; efficacy and safety data not yet poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TAF (tenofovir alafenamide)

Snippet

Sponsor: New Discovery LLC | Conditions: Hepatitis B, Chronic | Phase 4 | Status: UNKNOWN